In the Original Investigation titled “Blood Donors’ Preferences Toward Incentives for Donation in China,”1 published June 14, 2023, and in the Invited Commentary titled “Genome Sequencing for Newborn Screening—An Effective Approach for Tackling Rare Diseases,”2 published September 1, 2023, there were errors in the bylines. Shan Jiang’s degree should have been listed as an MSc. These articles have been corrected.1,2
Reference
- 1.Wang Y, Zhai P, Jiang S, Li C, Li S. Blood donors’ preferences toward incentives for donation in China. JAMA Netw Open. 2023;6(6):e2318320. doi: 10.1001/jamanetworkopen.2023.18320 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jiang S, Wang H, Gu Y. Genome sequencing for newborn screening—an effective approach for tackling rare diseases. JAMA Netw Open. 2023;6(9):e2331141. doi: 10.1001/jamanetworkopen.2023.31141 [DOI] [PubMed] [Google Scholar]